Correlation Between Cardio Diagnostics and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Kymera Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Kymera Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Kymera Therapeutics
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cardio and Kymera is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Kymera Therapeutics
Assuming the 90 days horizon Cardio Diagnostics Holdings is expected to under-perform the Kymera Therapeutics. In addition to that, Cardio Diagnostics is 2.02 times more volatile than Kymera Therapeutics. It trades about -0.31 of its total potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 3,914 in Kymera Therapeutics on October 20, 2024 and sell it today you would earn a total of 147.00 from holding Kymera Therapeutics or generate 3.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Kymera Therapeutics
Performance |
| Timeline |
| Cardio Diagnostics |
| Kymera Therapeutics |
Cardio Diagnostics and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Kymera Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Cardio Diagnostics vs. Agilent Technologies | Cardio Diagnostics vs. Equillium | Cardio Diagnostics vs. 23Andme Holding Co | Cardio Diagnostics vs. DiaMedica Therapeutics |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |